speb/financial-data huggingface dataset:
20MICRONS.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 108315000.00
20MICRONS.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 69704000.00
20MICRONS.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 8432000.00
20MICRONS.NS income_statement (annual, 2022-03-31) — Write Off: 1185000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1812566000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 7007562000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 787860000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 974673000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1429378000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -18096000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 87355000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 35286502.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Basic EPS: 11.85
20MICRONS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 127323000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 662801000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -124877000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -124877000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 59102000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 202819000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 296672000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 202819000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 137067000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -70730000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 29046000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Payable: -207078000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 34018000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -75691000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 75497000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2935786000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 167915000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 4469182000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2743761000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 16725000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 833497000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 850222000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1797654000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 1694000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Depreciation: 119570000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 119570000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 35286502.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 11.85
20MICRONS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 418191000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 182000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 0.00
20MICRONS.NS income_statement (annual, 2023-03-31) — EBIT: 669605000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — EBITDA: 789175000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 202819000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -379728000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 238552000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 507090000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 468000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 135126000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Goodwill: 216000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 18809000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 992769000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 3715899000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Gross Profit: 2538380000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 89000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 18474000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Interest Expense: 97681000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 97681000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Interest Income: 7750000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 7750000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -177632000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 7750000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Inventory: 1152385000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 3954976000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -176742000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 87444000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 3019000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 258115000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 392697000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 42377000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 185693000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 228070000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -99181000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 3019000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2371625000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 10525000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Minority Interests: -1426000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Net Debt: 816371000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 6988000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income: 418191000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 418191000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 419617000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 418191000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 418191000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 571022000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 419617000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -169882000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -69932000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -182385000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -99181000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -169882000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2286521000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -114559000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -83204000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2916977000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 13931000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 262941000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 41907000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 789587000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Normalized Income: 418493281.78
20MICRONS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 631967000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Operating Income: 725814000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 7007562000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 7266000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 2000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 18809000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 169368000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 1000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 5249000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 22303000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 52523000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 119539000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 5158000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 93853000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Other Special Charges: -46000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Payables: 845200000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3624000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 211746000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Pretax Income: 571924000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Properties: 1322000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -3318000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -69992000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -124877000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 913833000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 4469182000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 119570000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 38001000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 46639000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -182385000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 12360000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2279981000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 60000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 10318000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1034943000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1170069000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 35286502.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -83204000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Special Income Charges: -412000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2935786000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2916977000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -109718.22
20MICRONS.NS income_statement (annual, 2023-03-31) — Tax Provision: 152307000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 83501000.00
20MICRONS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -159560000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 5239198000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 3121479000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1078292000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2946311000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Total Expenses: 6281748000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2292887000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2495437000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 495233000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 79951000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 4635000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -412000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -412000.00
20MICRONS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 946107000.00
20MICRONS.NS income_statement (annual, 2023-03-31) — Write Off: 458000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1851163000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 7759804000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 620300000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1255210000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1526431000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -15855000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 3419000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 28813000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 169635000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 35286502.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Basic EPS: 15.89
20MICRONS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 202819000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 699515000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -198819000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -198819000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 57490000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 487467000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 606817000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 487467000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 24097000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 52541000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 53119000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Payable: -167616000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -309997000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -337313000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 284649000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3529537000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 203921000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 4989029000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 3319148000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 20222000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1036933000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1057155000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1895396000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 8289000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Depreciation: 140073000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 143492000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 35286502.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 15.89
20MICRONS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 560698000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2495000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: -26465000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — EBIT: 860547000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — EBITDA: 1004039000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 487467000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -28635000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 247914000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 345615000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 3056000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 120890000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 14486000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1271065000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3838126000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Gross Profit: 2770775000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 89000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Interest Expense: 90698000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 90698000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Interest Income: 10493000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 10493000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -164621000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 10493000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Inventory: 1128288000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 4690595000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -231150000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 169724000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 4546000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 367751000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 37268000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 124125000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 161393000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 4546000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 6446000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2428011000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 11440000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Minority Interests: -905000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Net Debt: 673591000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -3114000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income: 560698000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 560698000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 561604000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 560698000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 560698000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 768322000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 561603000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -158115000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -18967000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 137013000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -61568000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -158115000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2311695000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -196211000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 198581000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 3515051000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 13636000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 288689000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 6446000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 51748000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1013353000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Normalized Income: 567492552.77
20MICRONS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 544434000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Operating Income: 919612000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 7759804000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 35286502.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 537000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 3000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 14486000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 153543000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 81331000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -2000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 10327000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 25287000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 62456000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 137781000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 40966000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 119350000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Other Special Charges: 9276000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Payables: 702229000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 610000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 173429000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Pretax Income: 769849000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Properties: 1147000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -6168000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -18967000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -198819000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 880374000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4989029000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 143492000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 45791000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 55199000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 13945000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2813770000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 0.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 2608000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1037244000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1158134000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 35286502.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Special Income Charges: -9314000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 3529537000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 3515051000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2519447.23
20MICRONS.NS income_statement (annual, 2024-03-31) — Tax Provision: 208245000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.27
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 71143000.00
20MICRONS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -178533000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 5897979000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 3653662000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1218548000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 3540977000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Total Expenses: 6840192000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 2357002000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2578831000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 461606000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 77910000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 16978000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -9314000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -9314000.00
20MICRONS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1423752000.00
20MICRONS.NS income_statement (annual, 2024-03-31) — Write Off: 38000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 967604000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1595454000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 28813000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 239538000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 156518000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 87307000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 446968000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 3836465000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 50229000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 3940098000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 37865000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 974812000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1012677000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2248547000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 21242000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 13204000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2432545000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1592404000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 4993809000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 239538000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Investmentsin Associatesat Cost: 5243000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 118653000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 182532000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 301185000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 5243000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 9952000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 12261000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1070037000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2432545000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 3823261000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 12554000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 288215000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 271465000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 60214000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 3660032000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 13204000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 67726000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 2000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2382316000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 4994000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 359661000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 994769000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 35286502.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 3836465000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 3823261000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 6710909000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4018997000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1313862000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 3848726000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 2862183000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2770810000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 613636000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 27165000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 9497000.00
20MICRONS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1691551000.00
20MICRONS.NS income_statement (quarterly, 2024-12-31) — Other Special Charges: 9205000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 2265543000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 743875000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 9116589000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2274052000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 683771000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 683771000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1432276000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1432276000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1693636000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1693636000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 395010000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -15056000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -15056000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 3583000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 28813000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 28813000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 282464000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 282464000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 35286502.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 35313457.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Basic EPS: 17.68
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.31
20MICRONS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 487467000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 724605000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 724605000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -766800000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 137445000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 137445000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 312982000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 312982000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 393960000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 393960000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -44108000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 0.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 0.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 312982000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 312982000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -469432000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -38931000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -32141000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Payable: 63787000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -183275000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -654240000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -174484000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 176433000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 4293638000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4293638000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 166440000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 166440000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 5845041000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1289926000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 3731372000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 3731372000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 37995000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 37995000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1288738000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1288738000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1326733000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1326733000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2193068000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2193068000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 7472000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 7472000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Depreciation: 179001000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 182584000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 35286502.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 35313457.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 17.68
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.31
20MICRONS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 623763000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 152201000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 259000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 259000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: -44108000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — EBIT: 940218000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — EBIT: 238521000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — EBITDA: 1122802000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 238521000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 312982000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 96105000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 289326000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 289326000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -448936000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -226000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 153929000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 14097000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14097000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1447332000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1447332000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 4689313000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4689313000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Gross Profit: 3271548000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 984126000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 89000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 89000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Interest Expense: 113241000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 47673000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 113241000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 47673000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Interest Income: 13132000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 13132000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -181610000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 13132000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Inventory: 1597720000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1597720000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 5804455000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5804455000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -588453000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 282553000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 282553000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 24580000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 24580000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 778862000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 778862000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 99450000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 99450000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 222079000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 222079000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 321529000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 321529000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 24580000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 24580000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 8997000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 8997000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2764433000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2764433000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 46907000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 46907000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Minority Interests: -1084000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 81000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 126568000.00
20MICRONS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1197835000.00
20MICRONS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1197835000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 15154000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income: 623763000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income: 152201000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 623763000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 152201000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 624846000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 152120000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 623763000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 152201000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 623763000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 152201000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 826943000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 624847000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 152120000.00
20MICRONS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -168479000.00
20MICRONS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -47673000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 25026000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 354613000.00
20MICRONS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 97954000.00